oral resveratrol — Competitive Intelligence Brief

oral resveratrol (oral resveratrol) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: polyphenol. Area: Cardiovascular.

phase 3 polyphenol SIRT1 Cardiovascular Small molecule

Target snapshot

oral resveratrol (oral resveratrol) — Assistance Publique - Hôpitaux de Paris. Resveratrol acts as an activator of SIRT1, a protein that plays a role in cellular regulation and metabolism.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
oral resveratrol TARGET	oral resveratrol	Assistance Publique - Hôpitaux de Paris	phase 3	polyphenol	SIRT1
Resveratrol Pill	Resveratrol Pill	Russian Academy of Medical Sciences	marketed	Natural polyphenol / Sirtuin activator	SIRT1, antioxidant pathways, NF-κB
Mega Resveratrol® capsules	Mega Resveratrol® capsules	Sun Yat-sen University	phase 3	Polyphenolic antioxidant / Sirtuin activator	SIRT1, general antioxidant pathways, AMPK
Resveratrol nasal spray	Resveratrol nasal spray	University of Campania Luigi Vanvitelli	phase 3	Polyphenolic antioxidant	SIRT1, NF-κB pathway
SINECATECHINS	SINECATECHINS		marketed	Polyphenols	Unknown	2006-01-01
Veregen only	Veregen only	University of Texas Southwestern Medical Center	marketed	Botanical extract / polyphenol immunomodulator
green tea extract	green tea extract	Centro Universitario de Ciencias de la Salud, Mexico	marketed	Botanical extract / Polyphenol antioxidant

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

• 2026-10-02 — SINECATECHINS · 7858662 · Formulation · US

Sponsor landscape (polyphenol class)

1. Assistance Publique - Hôpitaux de Paris · 1 drug in this class